efaproxiral has been researched along with phosphocreatine in 2 studies
Studies (efaproxiral) | Trials (efaproxiral) | Recent Studies (post-2010) (efaproxiral) | Studies (phosphocreatine) | Trials (phosphocreatine) | Recent Studies (post-2010) (phosphocreatine) |
---|---|---|---|---|---|
76 | 13 | 10 | 7,475 | 329 | 575 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Becker, LC; Chacko, VP; DiPaula, AF; Gerstenblith, G; Kass, DA; Mejia, MA; Weiss, RG | 1 |
Bottomley, PA; Gerstenblith, G; Najjar, SS; Schulman, SP; Steffen, RP; Waldron, MM; Weiss, RG | 1 |
1 trial(s) available for efaproxiral and phosphocreatine
Article | Year |
---|---|
Effects of a pharmacologically-induced shift of hemoglobin-oxygen dissociation on myocardial energetics during ischemia in patients with coronary artery disease.
Topics: Adenosine Triphosphate; Aged; Analysis of Variance; Aniline Compounds; Antisickling Agents; Biomarkers; Blood Flow Velocity; Coronary Artery Disease; Coronary Circulation; Cross-Over Studies; Double-Blind Method; Exercise Test; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Myocardial Ischemia; Oxygen Consumption; Oxyhemoglobins; Phosphocreatine; Phosphorus Isotopes; Propionates; Treatment Outcome | 2005 |
1 other study(ies) available for efaproxiral and phosphocreatine
Article | Year |
---|---|
Preservation of canine myocardial high-energy phosphates during low-flow ischemia with modification of hemoglobin-oxygen affinity.
Topics: Aniline Compounds; Animals; Antisickling Agents; Dogs; Hemoglobins; Myocardial Ischemia; Oxygen; Oxygen Consumption; Phosphocreatine; Propionates | 1999 |